Deals, Partnering

TauRx Therapeutics enters collaborative R&D agreement with Bayer Schering Pharma

Posted on 03 June 2010

Tags: ,

Through this collaboration, the two companies will develop specific markers that will aid in the diagnostics and management of Tau-protein related AD using brain-imaging technology.

The diagnostics they are jointly aiming to develop will have application in disease treatment and potentially disease prevention.

Read full release at TauRx (link no longer available)

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new2gif
rauconbadgejpg
e78banner300x150animgif